Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients

Complete title: Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease

Research Study Number 9867
Principal Investigator Kanwaldeep Mallhi
Phase II

Research Study Description

This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are stratified into two groups: (1) children with SCD with strokes; and (2) adults with severe SCD.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "LOOK UP TRIAL AT NIH" link above. **

Other eligibility criteria may apply.

Research Study Number 9867

Keywords: Pediatric Cancers, Miscellaneous; Sickle Cell Anemia; Anemia; Genetic Diseases, Inborn; Anemia, Hemolytic; Hematologic Diseases; Anemia, Hemolytic, Congenital; Hemoglobinopathies

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials